Cardiovascular Systems, Inc. (CSII)
(Delayed Data from NSDQ)
$39.49 USD
+1.98 (5.28%)
Updated May 3, 2019 04:00 PM ET
After-Market: $39.52 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$39.49 USD
+1.98 (5.28%)
Updated May 3, 2019 04:00 PM ET
After-Market: $39.52 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Amedisys Buys 6 Home Health, Hospice Care Centers from Tenet
by Zacks Equity Research
Amedisys Inc. (AMED), a household name in home health and hospice services space, recently signed an exclusive agreement with Tenet Healthcare Corporation (THC).
Penumbra (PEN) Q4 Loss Narrower than Expected, Sales Top
by Zacks Equity Research
Penumbra, Inc. (PEN), that went public in Sep 2015, reported fourth-quarter 2016 loss of 8 cents per share, down from earnings of 5 cents per share year over year.
Mead Johnson Acquires Bega's Strategic Capabilities Business
by Zacks Equity Research
Mead Johnson Nutrition Company (MJN) recently inked an agreement with Bega Cheese Limited to acquire the latter's spray drying and finishing capabilities business in Australia.
Amedisys (AMED) Earnings Top Q4 Estimates, Revenues Lag
by Zacks Equity Research
Amedisys Inc. (AMED) reported adjusted earnings from continuing operations of 44 cents per share in the fourth quarter of 2016, up 10% year over year.
Why Is Cardiovascular Systems (CSII) Up 11.1% Since the Last Earnings Report?
by Zacks Equity Research
Cardiovascular Systems (CSII) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Medtronic (MDT) Presents 5-Year Cost Data of CRT Devices
by Zacks Equity Research
Medtronic plc (MDT) recently presented a five-year data report on cardiac resynchronization therapy (CRT) devices within its Cardiac Rhythm & Heart Failure (CRHF) division.
VWR Corporation (VWR) Tops Earnings in Q4; View Dull
by Zacks Equity Research
VWR Corporation (VWR) reported fourth-quarter 2016 adjusted earnings per share (EPS) of 45 cents, reflecting a 4.3% decline from the year-ago quarter.
Integra (IART) Posts In-Line Q4 Earnings, Issues 2017 View
by Zacks Equity Research
Integra LifeSciences Holdings Corporation (IART) reported adjusted earnings per share of 52 cents in the fourth quarter of 2016, up 18% from the year-ago adjusted number.
Medtronic Poised on Strong Fundamentals Despite Several Woes
by Zacks Equity Research
On Feb 23, we issued an updated research report on medical device major, Medtronic plc (MDT).
Omnicell: Q4 Report Disappoints, Aesynt Buyout Holds Promise
by Zacks Equity Research
On Feb 22, we issued an updated research report on Mountain View, CA-based Omnicell Inc. (OMCL).
Align Expands Internationally with Dental Couture Buyout
by Zacks Equity Research
Align Technology (ALGN) has recently announced the acquisition of Dubai, UAE and Nicosia, Cyprus-based distributor, G.L. Dental Couture Limited.
Henry Schein Inks Agreement for Rijuven's CardioSleeve
by Zacks Equity Research
Henry Schein, Inc. (HSIC) recently signed an exclusive distribution agreement with patient care platform designer Rijuven Corp. to sell the latter's CardioSleeve device
Henry Schein (HSIC) Tops Q4 Earnings, Reaffirms '17 View
by Zacks Equity Research
Henry Schein, Inc. (HSIC) reported adjusted earnings per share of $1.88 in the fourth quarter of 2016, up 12.6% year over year and surpassed the Zacks Consensus Estimate by 2.2%.
Ecolab's (ECL) Earnings, Revenues Miss Estimates in Q4
by Zacks Equity Research
Ecolab Inc. (ECL) reported fourth-quarter 2016 adjusted earnings of $1.25 per share, which missed the Zacks Consensus Estimate of $1.27.
Medtronic (MDT) Beats on Q3 Earnings, Retains Sales View
by Zacks Equity Research
Medtronic plc'S (MDT) third-quarter fiscal 2017 Adjusted earnings per share (EPS) came in at $1.12, a penny ahead of the Zacks Consensus Estimate.
Henry Schein to Acquire SAS to Strengthen Dental Offerings
by Zacks Equity Research
Henry Schein Inc. (HSIC) announced its decision to acquire Southern Anesthesia + Surgical (SAS).
GNC Holdings (GNC) Misses Q4 Earnings, Revenues Decline Y/Y
by Zacks Equity Research
GNC Holdings Inc. (GNC) reported fourth-quarter 2016 adjusted earnings per share (EPS) of 37 cents, down 88.1% and also missed the Zacks Consensus Estimate by 81.1%.
Medtronic's Freezor Xtra Catheter Gains FDA Nod for AVNRT
by Zacks Equity Research
Medtronic plc (MDT) recently announced the receipt of U.S. FDA approval for its Freezor Xtra Cryoablation Catheter to treat patients with atrioventricular nodal re-entrant tachycardia.
LabCorp (LH) Q4 Earnings and Revenues Beat, Offers View
by Zacks Equity Research
Laboratory Corporation of America Holdings (LH) or LabCorp reported fourth-quarter 2016 adjusted earnings per share (EPS) of $2.15, up 8.6% from the year-ago quarter.
Chemed (CHE) Misses Q4 Earnings, Sales; Offers '17 View
by Zacks Equity Research
Chemed Corp.'s (CHE) fourth-quarter 2016 adjusted earnings per share (EPS) was $2.02, missing the Zacks Consensus Estimate by 4.3%.
Omnicell (OMCL) Q4 Earnings Deteriorate Y/Y, Revenues Miss
by Zacks Equity Research
Omnicell, Inc. (OMCL) reported a breakeven in fourth-quarter 2016 earnings per share (EPS), a deterioration from the year-ago earnings of 5 cents.
Genomic Health (GHDX) Earnings Surpass Estimates in Q4
by Zacks Equity Research
Genomic Health, Inc. (GHDX) reported fourth-quarter 2016 earnings per share of 4 cents, reflecting an improvement from the year-ago quarter's loss figure of 8 cents.
Medtronic (MDT) Adds New Tools, Expands Coronary Suite
by Zacks Equity Research
Medtronic plc (MDT) recently added DxTerity Diagnostic Angiography Catheter line and several transradial-specific products to its market-leading coronary portfolio.
Bruker (BRKR) Beats on Q4 Earnings, Issues 2017 Guidance
by Zacks Equity Research
Bruker Corporation (BRKR) reported fourth quarter 2016 adjusted EPS of 46 cents, up 21.1% year over year and also surpassed the Zacks Consensus Estimate of 37 cents.
Omnicell Partners with DCH Health for Sterile Compounding
by Zacks Equity Research
Omnicell, Inc. (OMCL) recently formed an alliance with West Alabama's community-based health service provider, DCH Health System on sterile compounding operations.